| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/08/2001 | WO1999065449A8 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/08/2001 | DE19937537A1 Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate 2-substituted derivatives Dialkylaminoalkylbiphenyl |
| 03/08/2001 | CA2391844A1 Method and formula for tumor remission and suppression of cancer |
| 03/08/2001 | CA2388560A1 Sustained-release form of administration containing tramadol saccharinate |
| 03/08/2001 | CA2387291A1 Dna encoding the human serine protease t |
| 03/08/2001 | CA2384126A1 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383910A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 03/08/2001 | CA2383784A1 Apoptin-associating protein |
| 03/08/2001 | CA2383773A1 Methods and compositions for treating autoimmune disease |
| 03/08/2001 | CA2383693A1 Card proteins involved in cell death regulation |
| 03/08/2001 | CA2383606A1 Iren protein, its preparation and use |
| 03/08/2001 | CA2383381A1 Methods and compositions relating to body weight and eating disorders |
| 03/08/2001 | CA2383002A1 Substituted .alpha.-hydroxy acid caspase inhibitors and the use thereof |
| 03/08/2001 | CA2382989A1 Materials and methods for inhibition of ige production |
| 03/08/2001 | CA2382789A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | CA2382611A1 Compositions for stimulating cytokine secretion and inducing an immune response |
| 03/08/2001 | CA2382570A1 Treatment of allergic rhinitis |
| 03/08/2001 | CA2382427A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 03/08/2001 | CA2382345A1 Extended duration light activated cancer therapy |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/07/2001 | EP1081226A1 Apoptin-associating protein |
| 03/07/2001 | EP1081148A2 Enantiomerically pure beta-D-dioxolane-nucleosides |
| 03/07/2001 | EP1081146A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1081135A2 1H-indole-3-glyoxylamide spla2 inhibitors |
| 03/07/2001 | EP1080370A1 Identification of broadly reactive dr restricted epitopes |
| 03/07/2001 | EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 03/07/2001 | EP1080206A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiqitous endoproteases |
| 03/07/2001 | EP1080198A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080186A2 Method for altering the activity of proteins of the pka signaling pathway |
| 03/07/2001 | EP1080184A1 Method for activating natural killer (nk) cells |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080106A1 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080095A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/07/2001 | EP1080087A1 Novel 2-alkyl substituted imidazole compounds |
| 03/07/2001 | EP1080078A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 03/07/2001 | EP1080069A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1080055A2 24-hydroxyvitamin d, analogs and uses thereof |
| 03/07/2001 | EP1079862A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 03/07/2001 | EP1079860A1 Nicotine immunogen |
| 03/07/2001 | EP1079858A2 Oral immunization with papillomavirus virus-like particles |
| 03/07/2001 | EP1079857A1 Combination meningitidis b/c vaccines |
| 03/07/2001 | EP1079854A1 Compositions and methods of modulating an immune response to an antigen |
| 03/07/2001 | EP1079846A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 03/07/2001 | EP1079839A1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
| 03/07/2001 | EP1079832A1 Use of vitamin pp compounds |
| 03/07/2001 | EP1079831A1 Compositions for the treatment of hiv and other viral infections |
| 03/07/2001 | EP1079830A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE |
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP1079808A1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 03/07/2001 | EP1079804A1 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 03/07/2001 | EP0783505B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 03/07/2001 | EP0730597B1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them |
| 03/07/2001 | EP0730579B1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 03/07/2001 | CN1286696A Liposomes comprising peptide antigens derived from X protein of hepatitis B virus |
| 03/07/2001 | CN1286258A Purine L-nucleoside, analogs and use thereof |
| 03/07/2001 | CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286118A Oral liquid of chitosan and lucid ganoderma and its preparing process |
| 03/07/2001 | CN1286086A Application of leflunomide |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062858C Phenyl-substd alkenylcarboguanidides carrying perfluoroalkyl groups, process for their preparation, their use as medicament and medicines |
| 03/06/2001 | US6197982 Vitamin D analogues |
| 03/06/2001 | US6197936 Preparing container of serum protein; melting molding material and forming a parison, blowing a compressed gas into parison to form container, extrude serum protein into container, hermetically seal aperture to container |
| 03/06/2001 | US6197925 NF-AT polypeptides and polynucleotides |
| 03/06/2001 | US6197829 For the transplantation of organs and autoimmune diseases. in order to inhibit rejection reaction at organs or bone marrow and treat autoimmune diseases and allergic diseases; fingolimod is title compound |
| 03/06/2001 | US6197826 α-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation |
| 03/06/2001 | US6197810 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 03/06/2001 | US6197794 Antiinflamamtory agents; immunology diseases |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197781 Spray drying mixture of rapamycin suspension and carrier |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197774 Therapy for asthma, skin disorders |
| 03/06/2001 | US6197772 1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives |
| 03/06/2001 | US6197761 17β-2-oxo-tetrahydrofuranyl)-carbothioic acid ester, -carboxylic acid ester and -carboxylic acid amide androstane derivatives |
| 03/06/2001 | US6197755 Compositions and methods for delivery of genetic material |
| 03/06/2001 | US6197752 Tetrahydrofuran or tetrahydropyran compound; therapy for autoimmune disease, antiallergens, antiinflammatory agents |
| 03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/06/2001 | US6197746 Method of using secretin for treating autism |
| 03/06/2001 | US6197584 Antisense modulation of CD40 expression |
| 03/06/2001 | US6197583 Therapeutic compounds |
| 03/06/2001 | US6197582 Development of human monoclonal antibodies and uses thereof |
| 03/06/2001 | US6197571 Protein polysaccharide 0041 |
| 03/06/2001 | US6197525 Kit for detection of interleukin-17, interleukin-17 receptor, antagonists, or mimetics; includes receptor protein of defined amino acid sequence and a detecting reagent; for identifying immunosuppressants |
| 03/06/2001 | US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein |
| 03/06/2001 | US6197496 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80 |
| 03/06/2001 | US6197329 Anti-nausea compositions and methods |
| 03/06/2001 | US6197313 Ryegrass pollen allergen |
| 03/06/2001 | US6197302 Administering fusion protein of major histocompatibility complex complexed to immunoglobulin constant domain |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA1341197C Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use |
| 03/01/2001 | WO2001014886A2 Inhibitors of binding between proteins and macromolecular ligands |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |